Research and Development Center, GS Caltex Corporation, 104-4 Munji-dong, Daejeon, 305-380, Republic of Korea.
Microb Cell Fact. 2013 Feb 23;12:20. doi: 10.1186/1475-2859-12-20.
Klebsiella oxytoca, a Gram-negative, rod-shaped, and facultative anaerobic bacterium, is one of the most promising 2,3-butanediol (2,3-BD) producers. In order to improve the metabolic performance of K. oxytoca as an efficient biofactory, it is necessary to assess its metabolic characteristics with a system-wide scope, and to optimize the metabolic pathways at a systems level. Provision of the complete genome sequence of K. oxytoca enabled the construction of genome-scale metabolic model of K. oxytoca and its in silico analyses.
The genome-scale metabolic model of K. oxytoca was constructed using the annotated genome with biochemical and physiological information. The stoichiometric model, KoxGSC1457, is composed of 1,457 reactions and 1,099 metabolites. The model was further refined by applying biomass composition equations and comparing in silico results with experimental data based on constraints-based flux analyses. Then, the model was applied to in silico analyses to understand the properties of K. oxytoca and also to improve its capabilities for 2,3-BD production according to genetic and environmental perturbations. Firstly, in silico analysis, which tested the effect of augmenting the metabolic flux pool of 2,3-BD precursors, elucidated that increasing the pyruvate pool is primarily important for 2,3-BD synthesis. Secondly, we performed in silico single gene knockout simulation for 2,3-BD overproduction, and investigated the changes of the in silico flux solution space of a ldhA gene knockout mutant in comparison with that of the wild-type strain. Finally, the KoxGSC1457 model was used to optimize the oxygen levels during fermentation for 2,3-BD production.
The genome-scale metabolic model, KoxGSC1457, constructed in this study successfully investigated metabolic characteristics of K. oxytoca at systems level. The KoxGSC1457 model could be employed as an useful tool to analyze its metabolic capabilities, to predict its physiological responses according to environmental and genetic perturbations, and to design metabolic engineering strategies to improve its metabolic performance.
产酸克雷伯氏菌是一种革兰氏阴性、杆状、兼性厌氧细菌,是最有前途的 2,3-丁二醇(2,3-BD)生产菌之一。为了提高产酸克雷伯氏菌作为高效生物工厂的代谢性能,有必要从系统范围评估其代谢特性,并在系统水平上优化代谢途径。产酸克雷伯氏菌完整基因组序列的提供使得构建产酸克雷伯氏菌基因组规模代谢模型及其计算机分析成为可能。
使用具有生化和生理信息注释的基因组构建了产酸克雷伯氏菌的基因组规模代谢模型。该模型包含 1,457 个反应和 1,099 种代谢物,命名为 KoxGSC1457。通过应用生物量组成方程并根据基于约束通量分析的实验数据对计算机结果进行比较,对模型进行了进一步的细化。然后,应用该模型进行计算机分析,以了解产酸克雷伯氏菌的特性,并根据遗传和环境扰动来提高其 2,3-BD 生产能力。首先,通过计算机分析测试了增加 2,3-BD 前体代谢通量池的效果,结果表明增加丙酮酸池对 2,3-BD 合成尤为重要。其次,我们进行了计算机单基因敲除模拟,以实现 2,3-BD 的过量生产,并研究了与野生型菌株相比,ldhA 基因敲除突变体的计算机通量解空间的变化。最后,使用 KoxGSC1457 模型优化了 2,3-BD 发酵过程中的氧气水平。
本研究构建的基因组规模代谢模型 KoxGSC1457 成功地从系统水平上研究了产酸克雷伯氏菌的代谢特性。KoxGSC1457 模型可以作为一种有用的工具,分析其代谢能力,根据环境和遗传扰动预测其生理反应,并设计代谢工程策略来提高其代谢性能。